Skip to main content

Advertisement

Log in

Enhanced TGF-b/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor

  • ORIGINAL ARTICLE
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Angiotensin II (AII) and transforming growth factor-β (TGF-β) are closely involved in the pathogenesis of diabetic nephropathy (DN). AII is known to induce TGF-β production in resident renal cells, including glomerular mesangial cells and tubular epithelial cells. TGF-β receptor types I and II (TGF-βRI, II) are up-regulated in the diabetic kidney. The aim of this study was to clarify the role of AII in the regulation of the TGF-β system in the early stage of DN using AII type1a receptor-deficient(AT1a−/−) mice.

Methods

We investigated the expression of TGF-β1, TGF-βRI, II, and Smad signaling in AT1a−/− mice with streptozotocin (STZ)-induced DN. Mice were killed 10 and 20 days after the induction of hyperglycemia. The expression of TGF-β receptors was analyzed by immunohistochemical staining and reverse transcriptase–polymerase chain reaction (RT–PCR). TGF-β-specific Smad signaling was analyzed by electrophoretic mobility shift assay and Western blotting.

Results

The expression of both TGF-βRI and RII was up-regulated in the glomerular tufts and vasculature in diabetic AT1a+/+ mice kidney by immunohistochemistry. RT–PCR revealed that mRNAs for TGF-βRI and RII were also up-regulated. Smad2 and 4 protein levels were reduced in the renal cortex after the induction of diabetes, with an increase of Smad 3/4 complex in the nucleus. The expression of TGF-β receptors increased in both diabetic AT1a−/− and AT1a+/+ mice. Smad signaling in AT1a−/− mice was also enhanced.

Conclusions

Our results suggest that the complete blockade of the AT1a-mediated pathway has a minimal effect on the enhanced TGF-β/Smad signaling in the early stage of DN, at least in the AT1a−/− model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. G Wolf FN Ziyadeh (1999) ArticleTitleMolecular mechanisms of diabetic renal hypertrophy Kidney Int 56 393–405 Occurrence Handle10432377 Occurrence Handle10.1046/j.1523-1755.1999.00590.x Occurrence Handle1:CAS:528:DyaK1MXltlOhurs%3D

    Article  PubMed  CAS  Google Scholar 

  2. H Makino N Kashihara H Sugiyama K Kanao T Sekikawa K Okamoto et al. (1996) ArticleTitlePhenotypic modulation of the mesangium reflected by contractile proteins in diabetes Diabetes 45 488–95 Occurrence Handle8603771 Occurrence Handle10.2337/diabetes.45.4.488 Occurrence Handle1:CAS:528:DyaK28Xjs1Gjtbc%3D

    Article  PubMed  CAS  Google Scholar 

  3. AE Raptis G Viberti (2001) ArticleTitlePathogenesis of diabetic nephropathy Exp Clin Endocrinol Diabetes 109 IssueIDSuppl 2 S424–37 Occurrence Handle11460589 Occurrence Handle10.1055/s-2001-18600 Occurrence Handle1:CAS:528:DC%2BD3MXlslKnsr8%3D

    Article  PubMed  CAS  Google Scholar 

  4. G Wolf FN Ziyadeh (1997) ArticleTitleThe role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms Am J Kidney Dis 29 153–63 Occurrence Handle9002545 Occurrence Handle1:STN:280:ByiC2Mngs1w%3D

    PubMed  CAS  Google Scholar 

  5. DJ Leehey AK Singh N Alavi R Singh (2000) ArticleTitleRole of angiotensin II in diabetic nephropathy Kidney Int Suppl 77 S93–8 Occurrence Handle10997697 Occurrence Handle10.1046/j.1523-1755.2000.07715.x Occurrence Handle1:CAS:528:DC%2BD3cXms1Oiu7o%3D

    Article  PubMed  CAS  Google Scholar 

  6. C Hill A Logan C Smith H Gronbaek A Flyvbjerg (2001) ArticleTitleAngiotensin-converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats Diabetologia 44 495–500 Occurrence Handle11357481 Occurrence Handle10.1007/s001250051648 Occurrence Handle1:CAS:528:DC%2BD3MXit1GitbY%3D

    Article  PubMed  CAS  Google Scholar 

  7. H Peters WA Border NA Noble (1998) ArticleTitleTargeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade Kidney Int 54 1570–80 Occurrence Handle9844133 Occurrence Handle10.1046/j.1523-1755.1998.00164.x Occurrence Handle1:CAS:528:DyaK1cXnsVeqtLo%3D

    Article  PubMed  CAS  Google Scholar 

  8. EJ Lewis LG Hunsicker RP Bain RD Rohde (1993) ArticleTitleThe effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. Collaborative Study Group N Engl J Med 329 1456–62 Occurrence Handle8413456 Occurrence Handle10.1056/NEJM199311113292004 Occurrence Handle1:STN:280:ByuD3MbmtFM%3D

    Article  PubMed  CAS  Google Scholar 

  9. BM Brenner ME Cooper D de Zeeuw WF Keane WE Mitch HH Parving et al. (2001) ArticleTitleEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 861–9 Occurrence Handle11565518 Occurrence Handle10.1056/NEJMoa011161 Occurrence Handle1:CAS:528:DC%2BD3MXntlelsLk%3D

    Article  PubMed  CAS  Google Scholar 

  10. JH Song SH Cha HJ Lee SW Lee GH Park MJ Kim (2006) ArticleTitleEffect of low-dose dual blockade of the renin–angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease Nephrol Dial Transplant 21 683–9 Occurrence Handle16330466 Occurrence Handle10.1093/ndt/gfi310 Occurrence Handle1:CAS:528:DC%2BD28XhvVeksbw%3D

    Article  PubMed  CAS  Google Scholar 

  11. T Yamamoto NA Noble AH Cohen CC Nast A Hishida LI Gold et al. (1996) ArticleTitleExpression of transforming growth factor-beta isoforms in human glomerular diseases Kidney Int 49 461–9 Occurrence Handle8821830 Occurrence Handle1:STN:280:BymH3MbgsVE%3D

    PubMed  CAS  Google Scholar 

  12. S Kagami WA Border DE Miller NA Noble (1994) ArticleTitleAngiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells J Clin Invest 93 2431–7 Occurrence Handle8200978 Occurrence Handle1:CAS:528:DyaK2cXlsV2ktLw%3D

    PubMed  CAS  Google Scholar 

  13. T Yamamoto T Nakamura NA Noble E Ruoslahti WA Border (1993) ArticleTitleExpression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy Proc Natl Acad Sci USA 90 1814–8 Occurrence Handle7680480 Occurrence Handle10.1073/pnas.90.5.1814 Occurrence Handle1:CAS:528:DyaK3sXhs1KmsLs%3D

    Article  PubMed  CAS  Google Scholar 

  14. WA Border T Yamamoto NA Noble (1996) ArticleTitleTransforming growth factor beta in diabetic nephropathy Diabetes Metab Rev 12 309–39 Occurrence Handle9013074 Occurrence Handle10.1002/(SICI)1099-0895(199612)12:4<309::AID-DMR171>3.0.CO;2-A Occurrence Handle1:CAS:528:DyaK2sXhtFGlt7g%3D

    Article  PubMed  CAS  Google Scholar 

  15. W Wang V Koka HY Lan (2005) ArticleTitleTransforming growth factor-beta and Smad signalling in kidney diseases Nephrology (Carlton) 10 48–56 Occurrence Handle10.1111/j.1440-1797.2005.00334.x

    Article  Google Scholar 

  16. E Gagliardini A Benigni (2006) ArticleTitleRole of anti-TGF-beta antibodies in the treatment of renal injury Cytokine Growth Factor Rev 17 89–96 Occurrence Handle16257566 Occurrence Handle10.1016/j.cytogfr.2005.09.005 Occurrence Handle1:CAS:528:DC%2BD28Xos1CrtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  17. M Stopa D Anhuf L Terstegen P Gatsios AM Gressner S Dooley (2000) ArticleTitleParticipation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation J Biol Chem 275 29308–17 Occurrence Handle10887185 Occurrence Handle10.1074/jbc.M003282200 Occurrence Handle1:CAS:528:DC%2BD3cXmvFGqu7c%3D

    Article  PubMed  CAS  Google Scholar 

  18. K Okamoto N Kashihara H Sugiyama T Sekikawa Y Maeshima K Kanao et al. (1997) ArticleTitleSuppression of phenotypic alteration of mesangial cells in diabetes induced in angiotensin II type 1a receptor deficient mice J Am Soc Nephrol 8 644A

    Google Scholar 

  19. T Sugaya S Nishimatsu K Tanimoto E Takimoto T Yamagishi K Imamura et al. (1995) ArticleTitleAngiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia J Biol Chem 270 18719–22 Occurrence Handle7642517 Occurrence Handle10.1074/jbc.270.32.18719 Occurrence Handle1:CAS:528:DyaK2MXnsVOjt74%3D

    Article  PubMed  CAS  Google Scholar 

  20. AA Like AA Rossini (1976) ArticleTitleStreptozotocin-induced pancreatic insulitis: new model of diabetes mellitus Science 193 415–7 Occurrence Handle180605 Occurrence Handle10.1126/science.180605 Occurrence Handle1:CAS:528:DyaE28XkvFWlsrs%3D

    Article  PubMed  CAS  Google Scholar 

  21. Y Maeshima N Kashihara T Yasuda H Sugiyama T Sekikawa K Okamoto et al. (1998) ArticleTitleInhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo J Clin Invest 101 2589–97 Occurrence Handle9616230

    PubMed  Google Scholar 

  22. M Satoh N Kashihara Y Yamasaki K Maruyama K Okamoto Y Maeshima et al. (2001) ArticleTitleRenal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice J Am Soc Nephrol 12 317–25 Occurrence Handle11158221 Occurrence Handle1:CAS:528:DC%2BD3MXhtl2msLo%3D

    PubMed  CAS  Google Scholar 

  23. S Okada K Shikata M Matsuda D Ogawa H Usui Y Kido et al. (2003) ArticleTitleIntercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes Diabetes 52 2586–93 Occurrence Handle14514644 Occurrence Handle10.2337/diabetes.52.10.2586 Occurrence Handle1:CAS:528:DC%2BD3sXotVWhsb0%3D

    Article  PubMed  CAS  Google Scholar 

  24. T Yamamoto T Watanabe N Ikegaya Y Fujigaki K Matsui H Masaoka et al. (1998) ArticleTitleExpression of types I, II, and III TGF-beta receptors in human glomerulonephritis J Am Soc Nephrol 9 2253–61 Occurrence Handle9848779 Occurrence Handle1:CAS:528:DyaK1cXotVKnsr0%3D

    PubMed  CAS  Google Scholar 

  25. C Hill A Flyvbjerg H Gronbaek J Petrik DJ Hill CR Thomas et al. (2000) ArticleTitleThe renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats Endocrinology 141 1196–208 Occurrence Handle10698197 Occurrence Handle10.1210/en.141.3.1196 Occurrence Handle1:CAS:528:DC%2BD3cXisFOrt70%3D

    Article  PubMed  CAS  Google Scholar 

  26. FN Ziyadeh DC Han (1997) ArticleTitleInvolvement of transforming growth factor-beta and its receptors in the pathogenesis of diabetic nephrology Kidney Int Suppl 60 S7–11 Occurrence Handle9285895 Occurrence Handle1:CAS:528:DyaK2sXmt1Cqt7c%3D

    PubMed  CAS  Google Scholar 

  27. SW Hong M Isono S Chen MC Iglesias-De La Cruz DC Han FN Ziyadeh (2001) ArticleTitleIncreased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse Am J Pathol 158 1653–63 Occurrence Handle11337363 Occurrence Handle1:STN:280:DC%2BD3MzlsF2jtA%3D%3D

    PubMed  CAS  Google Scholar 

  28. A Erman S Veksler U Gafter G Boner C Wittenberg DJ van Dijk (2004) ArticleTitleRenin–angiotensin system blockade prevents the increase in plasma transformIng growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin diabetic rat J Renin Angiotensin Aldosterone Syst 5 146–51 Occurrence Handle15526251 Occurrence Handle1:CAS:528:DC%2BD2cXhtVSjt7%2FP

    PubMed  CAS  Google Scholar 

  29. J Liao M Kobayashi Y Kanamuru S Nakamura Y Makita K Funabiki et al. (2003) ArticleTitleEffects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice J Nephrol 16 841–9 Occurrence Handle14736011 Occurrence Handle1:CAS:528:DC%2BD2cXhvFajtbY%3D

    PubMed  CAS  Google Scholar 

  30. JY Guh ML Yang YL Yang CC Chang LY Chuang (1996) ArticleTitleCaptopril reverses high-glucose-induced growth effects on LLC-PK1 cells partly by decreasing transforming growth factor-beta receptor protein expressions J Am Soc Nephrol 7 1207–15 Occurrence Handle8866414 Occurrence Handle1:CAS:528:DyaK28XlslKiu74%3D

    PubMed  CAS  Google Scholar 

  31. L Mishra B Marshall (2006) ArticleTitleAdaptor proteins and ubiquinators in TGF-beta signaling Cytokine Growth Factor Rev 17 75–87 Occurrence Handle16359909 Occurrence Handle10.1016/j.cytogfr.2005.09.001 Occurrence Handle1:CAS:528:DC%2BD28Xos1CrtA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  32. M Isono S Chen SW Hong MC Iglesias-de la Cruz FN Ziyadeh (2002) ArticleTitleSmad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells Biochem Biophys Res Commun 296 1356–65 Occurrence Handle12207925 Occurrence Handle10.1016/S0006-291X(02)02084-3 Occurrence Handle1:CAS:528:DC%2BD38Xms1Wlt70%3D

    Article  PubMed  CAS  Google Scholar 

  33. HC Huang PA Preisig (2000) ArticleTitleG1 kinases and transforming growth factor-beta signaling are associated with a growth pattern switch in diabetes-induced renal growth Kidney Int 58 162–72 Occurrence Handle10886561 Occurrence Handle10.1046/j.1523-1755.2000.00151.x Occurrence Handle1:CAS:528:DC%2BD3cXltVyjtLg%3D

    Article  PubMed  CAS  Google Scholar 

  34. M Ruiz-Ortega M Ruperez V Esteban J Rodriguez-Vita E Sanchez-Lopez G Carvajal et al. (2006) ArticleTitleAngiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases Nephrol Dial Transplant 21 16–20 Occurrence Handle16280370 Occurrence Handle10.1093/ndt/gfi265 Occurrence Handle1:CAS:528:DC%2BD28XisFKhtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  35. J Rodriguez-Vita E Sanchez-Lopez V Esteban M Ruperez J Egido M Ruiz-Ortega (2005) ArticleTitleAngiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism Circulation 111 2509–17 Occurrence Handle15883213 Occurrence Handle10.1161/01.CIR.0000165133.84978.E2 Occurrence Handle1:CAS:528:DC%2BD2MXjvFOisro%3D

    Article  PubMed  CAS  Google Scholar 

  36. JH Li XR Huang HJ Zhu M Oldfield M Cooper LD Truong et al. (2004) ArticleTitleAdvanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease Faseb J 18 176–8 Occurrence Handle12709399 Occurrence Handle10.1096/fj.04-2273com Occurrence Handle1:CAS:528:DC%2BD2cXhtVKru7bJ

    Article  PubMed  CAS  Google Scholar 

  37. J Yue KM Mulder (2000) ArticleTitleRequirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway J Biol Chem 275 30765–73 Occurrence Handle10843986 Occurrence Handle10.1074/jbc.M000039200 Occurrence Handle1:CAS:528:DC%2BD3cXntlCjtLY%3D

    Article  PubMed  CAS  Google Scholar 

  38. W Wang XR Huang E Canlas K Oka LD Truong C Deng et al. (2006) ArticleTitleEssential role of Smad3 in angiotensin II-induced vascular fibrosis Circ Res 98 1032–9 Occurrence Handle16556868 Occurrence Handle10.1161/01.RES.0000218782.52610.dc Occurrence Handle1:CAS:528:DC%2BD28Xjs1Kltrk%3D

    Article  PubMed  CAS  Google Scholar 

  39. T Matsusaka Y Miyazaki I Ichikawa (2002) ArticleTitleThe renin angiotensin system and kidney development Annu Rev Physiol 64 551–61 Occurrence Handle11826279 Occurrence Handle10.1146/annurev.physiol.64.081501.155721 Occurrence Handle1:CAS:528:DC%2BD38XisFGmsb0%3D

    Article  PubMed  CAS  Google Scholar 

  40. W Wang XR Huang AG Li F Liu JH Li LD Truong et al. (2005) ArticleTitleSignaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7 J Am Soc Nephrol 16 1371–83 Occurrence Handle15788474 Occurrence Handle10.1681/ASN.2004121070 Occurrence Handle1:CAS:528:DC%2BD2MXksF2gsLk%3D

    Article  PubMed  CAS  Google Scholar 

  41. K Uchida H Suzuki T Ohashi K Nitta W Yumura H Nihei (2001) ArticleTitleInvolvement of MAP kinase cascades in Smad7 transcriptional regulation Biochem Biophys Res Commun 289 376–81 Occurrence Handle11716483 Occurrence Handle10.1006/bbrc.2001.5984 Occurrence Handle1:CAS:528:DC%2BD3MXosFGitL0%3D

    Article  PubMed  CAS  Google Scholar 

  42. A Nakao M Fujii R Matsumura K Kumano Y Saito K Miyazono et al. (1999) ArticleTitleTransient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice J Clin Invest 104 5–11 Occurrence Handle10393693 Occurrence Handle1:CAS:528:DyaK1MXktlOgsL8%3D Occurrence Handle10.1172/JCI6094

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuko Okazaki.

About this article

Cite this article

Okazaki, Y., Yamasaki, Y., Uchida, H. et al. Enhanced TGF-b/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor. Clin Exp Nephrol 11, 77–87 (2007). https://doi.org/10.1007/s10157-006-0456-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-006-0456-1

Key words

Navigation